DCDaniel J. Cua

Daniel J. Cua

*This is an algorithmically generated author record based on publicly available information.

Daniel J. Cua has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Robert A. Kastelein

    Discovery Research, Schering-Plough Biopharma, Palo Alto, California, USA. 2Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3Experimental Pathology and Pharmacology and 4Protein Engineering, Schering-Plough Biopharma, Palo Alto, California, USA

    5 shared publications
  • Claire L. Langrish

    Discovery Research, Schering-Plough Biopharma, Palo Alto, California, USA. 2Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3Experimental Pathology and Pharmacology and 4Protein Engineering, Schering-Plough Biopharma, Palo Alto, California, USA

    4 shared publications
  • Terrill McClanahan

    Discovery Research, Schering-Plough Biopharma, Palo Alto, California, USA. 2Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3Experimental Pathology and Pharmacology and 4Protein Engineering, Schering-Plough Biopharma, Palo Alto, California, USA

    3 shared publications
  • Yi Chen

    Discovery Research, DNAX Research Inc., Palo Alto, CA 94304

    3 shared publications
  • Craig A. Murphy

    Discovery Research, DNAX Research Inc, Palo Alto, CA 94304, USA

    2 shared publications
  • Wendy Blumenschein

    Discovery Research, Schering-Plough Biopharma, Palo Alto, California, USA. 2Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3Experimental Pathology and Pharmacology and 4Protein Engineering, Schering-Plough Biopharma, Palo Alto, California, USA

    2 shared publications

Latest Publications

  • TGF-β, a 'double agent' in the immune pathology war

    by Daniel J Cua, Robert A Kastelein


  • Open Access

    Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

    by Y. Chen, Claire L. Langrish, Brent Mckenzie, Barbara Joyce-Shaikh, Jason S. Stumhofer, Terrill McClanahan, Wendy Blumenschein, Tatyana Churakovsa, Justin Low, Leonard Presta, et al.

    IL-23 is a member of the IL-12 cytokine family that drives a highly pathogenic T cell population involved in the initiation of autoimmune diseases. We have shown that IL-23–dependent, pathogenic T cells produced IL-17A, IL-17F, IL-6, and TNF but not IFN-γ or IL-4. We now show that T-bet and STAT1 transcription factors are not required for the initial production of IL-17. However, optimal IL-17 production in response to IL-23 stimulation appears to require the presence of T-bet. To explore the clinical efficacy of targeting the IL-23 immune pathway, we generated anti–IL-23p19–specific antibodies and tested to determine whether blocking IL-23 function can inhibit EAE, a preclinical animal model of human multiple sclerosis. Anti–IL-23p19 treatment reduced the serum level of IL-17 as well as CNS expression of IFN-γ, IP-10, IL-17, IL-6, and TNF mRNA. In addition, therapeutic treatment with anti–IL-23p19 during active disease inhibited proteolipid protein (PLP) epitope spreading and prevented subsequent disease relapse. Thus, therapeutic targeting of IL-23 effectively inhibited multiple inflammatory pathways that are critical for driving CNS autoimmune inflammation.


  • Top Cited Papers
    Open Access

    IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

    by Claire L. Langrish, Yi Chen, Wendy M. Blumenschein, Jeanine Mattson, Beth Basham, Jonathan D. Sedgwick, Terrill McClanahan, Robert A. Kastelein, Daniel J. Cua

    Interleukin (IL)-23 is a heterodimeric cytokine composed of a unique p19 subunit, and a common p40 subunit shared with IL-12. IL-12 is important for the development of T helper (Th)1 cells that are essential for host defense and tumor suppression. In contrast, IL-23 does not promote the development of interferon-γ–producing Th1 cells, but is one of the essential factors required for the expansion of a pathogenic CD4+ T cell population, which is characterized by the production of IL-17, IL-17F, IL-6, and tumor necrosis factor. Gene expression analysis of IL-23–driven autoreactive T cells identified a unique expression pattern of proinflammatory cytokines and other novel factors, distinguishing them from IL-12–driven T cells. Using passive transfer studies, we confirm that these IL-23–dependent CD4+ T cells are highly pathogenic and essential for the establishment of organ-specific inflammation associated with central nervous system autoimmunity.


  • IL‐12 and IL‐23: master regulators of innate and adaptive immunity

    by Claire L. Langrish, Brent S. McKenzie, Nicholas J. Wilson, Rene De Waal Malefyt, Robert A. Kastelein, Daniel J. Cua

    Summary:  Initiation of an effective immune response requires close interactions between innate and adaptive immunity. Recent advances in the field of cytokine biology have led to an increased understanding of how myeloid cell‐derived factors regulate the immune system to protect the host from infections and prevent tumor development. In this review, we focus on the function of interleukin (IL)‐23, a new member of the IL‐12 family of regulatory cytokines produced by activated macrophages and dendritic cells. We propose that IL‐12 and IL‐23 promote two distinct immunological pathways that have separate but complementary functions. IL‐12 is required for antimicrobial responses to intracellular pathogens, whereas IL‐23 is likely to be important for the recruitment and activation of a range of inflammatory cells that is required for the induction of chronic inflammation and granuloma formation. These two cytokines work in concert to regulate cellular immune responses critical for host defense and tumor suppression.


  • Top Cited Papers
    Open Access

    Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation

    by Craig A. Murphy, Claire L. Langrish, Yi Chen, Wendy Blumenschein, Terrill McClanahan, Robert A. Kastelein, Jonathon D. Sedgwick, Daniel J. Cua

    Interleukin (IL) 23 is a heterodimeric cytokine composed of a p19 subunit and the p40 subunit of IL-12. IL-23 affects memory T cell and inflammatory macrophage function through engagement of a novel receptor (IL-23R) on these cells. Recent analysis of the contribution of IL-12 and IL-23 to central nervous system autoimmune inflammation demonstrated that IL-23 rather than IL-12 was the essential cytokine. Using gene-targeted mice lacking only IL-12 (p35−/−) or IL-23 (p19−/−), we show that the specific absence of IL-23 is protective, whereas loss of IL-12 exacerbates collagen-induced arthritis. IL-23 gene-targeted mice did not develop clinical signs of disease and were completely resistant to the development of joint and bone pathology. Resistance correlated with an absence of IL-17–producing CD4+ T cells despite normal induction of collagen-specific, interferon-γ–producing T helper 1 cells. In contrast, IL-12–deficient p35−/− mice developed more IL-17–producing CD4+ T cells, as well as elevated mRNA expression of proinflammatory tumor necrosis factor, IL-1β, IL-6, and IL-17 in affected tissues of diseased mice. The data presented here indicate that IL-23 is an essential promoter of end-stage joint autoimmune inflammation, whereas IL-12 paradoxically mediates protection from autoimmune inflammation.


  • Top Cited Papers

    Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

    by Daniel J. Cua, Jonathan Sherlock, Yi Chen, Craig A. Murphy, Barbara Joyce, Brian Seymour, Linda Lucian, Wayne To, Sylvia Kwan, Tatyana Churakova, et al.

    Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.